Synopsys (NASDAQ:SNPS) Upgraded at Zacks Research

Synopsys (NASDAQ:SNPS) was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports.

A number of other brokerages have also commented on SNPS. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Rosenblatt Securities upped their price target on shares of Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Morgan Stanley raised their price target on shares of Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Citigroup lifted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, Bank of America upped their target price on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and an average price target of $570.06.

Synopsys Stock Performance

NASDAQ SNPS opened at $454.53 on Tuesday. The firm has a 50-day moving average of $483.60 and a 200-day moving average of $461.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a market cap of $87.03 billion, a PE ratio of 105.22, a P/E/G ratio of 2.62 and a beta of 1.22. Synopsys has a 52-week low of $376.18 and a 52-week high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts anticipate that Synopsys will post 10.65 EPS for the current year.

Insider Transactions at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Synopsys

Several hedge funds have recently added to or reduced their stakes in SNPS. Sankala Group LLC bought a new position in shares of Synopsys during the fourth quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys in the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys in the fourth quarter valued at $28,000. Atlas Capital Advisors Inc. acquired a new stake in Synopsys in the fourth quarter valued at $32,000. Finally, Phillip James Consulting Co. bought a new position in Synopsys during the 4th quarter worth $36,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.